This study assessed the prevalence of auto-Abs neutralizing 10 ng/mL IFN-α2 and IFN-ω in critically ill COVID-19 patients from a Brazilian cohort and their association with clinical outcomes. This evidence concerns the gene IFNA2 and COVID-19.